Torrey Pines Therapeutics is a biopharmaceutical company based in La Jolla, California. They specialize in the discovery and development of small molecule drugs to treat diseases and disorders of the central nervous system. With a focus on novel drug targets and technologies, Torrey Pines aims to deliver new therapies for conditions such as migraine chronic pain, neuropathic pain, Alzheimer's disease, and schizophrenia.
Recently, Torrey Pines completed a merger with Raptor Pharmaceuticals Corp., forming a new biopharmaceutical company named Raptor Pharmaceutical Corp. The combined company, headquartered in Novato, California, is led by an experienced management team and has a robust pipeline of mid- and late-stage product candidates. They are dedicated to improving the lives of patients with unmet medical needs and are actively working towards important milestones in their clinical trials.
Generated from the website